ArticleBMC public health2025
Prevalence and spatial distributions of trachomatous inflammation-follicular among children aged 1-9 years in rural areas of Yilmana Densa and Gonji Kolela districts, Northwestern Ethiopia.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTrachoma is the world's major infectious cause of blindness, responsible for blinding 1.9 million people, including 1.2 million irreversibly. It is still endemic predominantly in sub-Saharan Africa, including Ethiopia. Five or more follicles in the upper tarsal conjunctiva measuring at least 0.5 mm indicate trachomatous inflammation-follicular (TF) disease. No previous study determined the prevalence of TF, and it had not been determined for the study area to satisfy adequate geospatial representation/spatial distribution of TF among children 1-9 years old. These study findings can help programmers understand the prevalence of TF and identify the villages in the study area where TF will be clustered to implement appropriate intervention strategies to support the current trachoma control and elimination program and to help achieve SDG Goal 3 target 3.3 and Goal 6. Therefore, this study addressed those gaps by identifying TF's prevalence and spatial distribution using spatial analytical techniques and models in Yilmana Densa and Gonji Kolela Districts.
methodsThe study utilizes spatial autocorrelation methodologies, including Global Moran's I and Local Getis-Ord statistics, to describe and map spatial clusters. The global Moran's I statistic was used to evaluate the global spatial autocorrelation of TF prevalence. The Gi_Bin field was computed in hot spot spatial analysis, independent of the False Discovery Rate correction (FDR), to detect important hot spots and cold spots. Bins of +/-3, +/-2, and +/-1 indicated statistically significant clustering of the TF distribution with 99%, 95%, and 90% confidence levels, respectively. However, non-significant TF clusters were identified with a 0 bin.
resultsThis study found that the prevalence of TF was 17.8% (95% CI: 15.3-20.2%). From spatial analytical techniques and models, the global spatial autocorrelation analysis based on feature locations and attribute values revealed a clustering of TF among children aged 1-9 years across the study area (Global Moran's I = 0.849, p-value < 0.0001). In hot spot spatial analysis, fourteen hot spot clusters were detected. Eight clusters were detected as significantly clustered from those fourteen hot spot areas at the 99% confidence level. The study also found that the distribution of TF was not spatially random. It was clustered at the village levels and showed strong spatial patterns. It was affected by different locations based on sociodemographic, environmental, and behavioral factors. It was more clustered in Gonji Kolela District compared to Yilmana Densa District. This study showed that trachoma is a family-based disease.
conclusionTF was found to be higher than the WHO recommended threshold of 10% to say that trachoma is a severe public health problem to conduct MDA and eliminate trachoma as a Public Health problem in a community when the prevalence of TF is less than 5%. The results of the study may be used to support the current trachoma control and elimination program, and to help achieve SDG Goal 3 target 3.3 and Goal 6. Intervention against TF may also have an impact on poverty (SDG1) and hunger (SDG2), may improve education (SDG4), work, and economic growth (SDG8). These will be helpful to decide whether the Yilmana Densa and Gonji Kolela Districts meet VISION 2020, "The Right to Sight" (elimination of the major causes of avoidable blindness), an initiative launched in Ethiopia in September 2002. It is recommended that coordinated work on implementing the WHO endorsed SAFE strategy in particular, and enhancing the overall living conditions of the community be given a high priority.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.